Matthew R Patterson
CIK 1401018 · Chief Executive Officer · last filed 2025-05-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BOLD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
6 CEDAR BROOK DRIVE
CRANBURY, NJ 08512
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VOR | Director | — | $19.08 | — | $0 | 5 | 2025-05-23 |
| FIXX | Director | — | $8.98 | — | $0 | 6 | 2023-06-15 |
| 5:01 Acquisition Corp. (FVAM) Delisted | Director | — | $10.00 | — | $0 | 1 | 2020-10-20 |
| BOLD | Chief Executive Officer | 0 | $2.41 | $0 | -$7.92M | 21 | 2020-01-15 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Acting CEO & President | 106,547 | $14.49 | $1.54M | -$489.4K | 21 | 2011-04-19 |
Recent Filings · Page 5 of 6
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-10-24 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −3,200 | -$33.3K | EDGAR |
| 2008-10-22 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −4,500 | -$47.8K | EDGAR |
| 2008-08-21 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −2,000 | -$27.1K | EDGAR |
| 2008-08-20 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −8,000 | -$115.6K | EDGAR |
| 2008-07-22 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −1,900 | -$20.9K | EDGAR |
| 2008-07-22 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −600 | -$6.7K | EDGAR |
| 2008-06-24 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −1,400 | -$16.0K | EDGAR |
| 2008-06-20 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −1,900 | -$20.9K | EDGAR |
| 2008-06-18 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −6,700 | -$74.7K | EDGAR |
| 2008-04-16 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −5,500 | -$57.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.